Cryo-Cell International, Inc. engages in cord blood and cord tissue cryopreservation services in the United States. The company offers cellular processing and cryogenic storage for family use, primarily for collection and preservation of umbilical cord blood, and tissue stem cells; and cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. It is also involved in the manufacturing of PrepaCyte CB processing system units for processing umbilical cord blood stem cells. In addition, the company provides cold storage services to third-party pharmaceutical companies and medical institutions. It markets its cord blood stem cell preservation services directly to expectant parents, as well as by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals. The company was incorporated in 1989 and is headquartered in Oldsmar, Florida.
Frequently asked questions
What sector does CryoCell International Inc (CCEL) operate in?
CryoCell International Inc belongs to the Healthcare sector and operates in the Medical Care Facilities industry.
What is CryoCell International Inc (CCEL) current stock price?
As of the latest data, CryoCell International Inc stock price is $5.01, with a previous close of $4.46. CryoCell International Inc gained $0.56 in the last trading session, representing a 12.46% increase.
What is CryoCell International Inc (CCEL) current market capitalization?
CryoCell International Inc market cap is approximately 40.39 million.
What is CryoCell International Inc (CCEL) Earnings Per Share (EPS)?
The trailing EPS is -$0.24, and the forward EPS is $0.02.
What is CryoCell International Inc (CCEL) EBITDA?
CryoCell International Inc EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 2.53 million.
Does CryoCell International Inc (CCEL) pay dividends?
No. CryoCell International Inc does not pay a dividend.
How did CryoCell International Inc (CCEL) perform in its most recent earnings report?
In the last report (August 31, 2026), CryoCell International Inc posted an EPS surprise of 433.33% and a revenue surprise of 4.98%.
What is CryoCell International Inc (CCEL) beta (volatility) score?
CryoCell International Inc has a beta of 0.590, indicating lower volatility than the overall market.
